Quest Diagnostics news
The WiseView Research desk's stories that name Quest Diagnostics, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The DGX page →
- HeadlineWhy Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
- HeadlineQuest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's
- HeadlineLab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach
- HeadlineWhy Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
- HeadlineDGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
- HeadlineWhat Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
- HeadlineQuest Diagnostics: 3 Key Takeaways for Long-Term Investors
- HeadlineQuest Diagnostics Incorporated (DGX) Q3 2026 Earnings Call Transcript
- HeadlineQuest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
- HeadlineQuest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
- HeadlineA new at-home HPV test kit is going national through Quest Diagnostics
- HeadlineCurrent Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension
- HeadlineHere's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
- CongressRo Khanna bought $1,001 - $15,000 of DGX
- HeadlineHere's Why Quest Diagnostics (DGX) is a Strong Value Stock
- HeadlineHaystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
- CongressJulie Johnson bought $1,001 - $15,000 of DGX
- CongressJulie Johnson sold $1,001 - $15,000 of DGX
- CongressAlan Armstrong bought $1,001 - $15,000 of DGX
- CongressJulie Johnson sold $1,001 - $15,000 of DGX
- CongressGilbert Cisneros sold $1,001 - $15,000 of DGX
- CongressRo Khanna bought $1,001 - $15,000 of DGX
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.